cervical cancer
Conditions
Interventions
observation group:Concurrent chemoradiotherapy
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Pathological diagnosis of cervical cancer; 2. ECOG =2; 3. Aged from 18 to 70 years; 4. Imaging digonised or pathological diagonised Para aortic lymph node or Common iliac artery lymph node metastasis; 5. FIGO stages IB-IIIB with or without para arotic lymph node metastasis; 6. no other distant metasitasis; 7. without any other cancer; 8. never received radiotherapy or chemotherapy; 9. WBC=3.5×10^9/L; NEUT=2×10^9/L; HGB=90g/dL; PLT=100×10^9/L; Cr<1.5mg/dlALT<100u/L.
Exclusion criteria
Exclusion criteria: 1. refuse Concurrent chemoradiotherapy; 2. cannt afford Concurrent chemoradiotherapy; 3. cannt not to do intracavitary brachytherapy; 4. find distant metastasis during the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| evaluated the acute toxic reactions for the patients who diagnosed cervical cancer with Para aortic lymph node or Common iliac artery lymph node metastasis and received extended-field IMRT plus concurrent chemotherapy plus brachytherapy;evaluated the chronic toxic reactions for the same patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| evaluated the clinical efficacy, such as overall survival rate, tumor free survival rate, Pelvic recurrence rate, para-aortic recurrence rate and non-para aortic metastasis rate etc.; | — |
Countries
China
Contacts
Public ContactHu Ke
Peking Union Medical College Hospital
Outcome results
None listed